International Aids Vaccine
The International AIDS Vaccine Initiative (IAVI) is a 501(c)(3) nonprofit scientific research organization headquartered at 125 Broad Street, 9th Floor, New York, NY 10004. Founded in 1996, IAVI develops vaccines and monoclonal antibodies for diseases with high unmet medical need, including HIV, tuberculosis, and emerging infectious diseases with pandemic potential that lack commercial incentives.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$129.9M
+4.5% YoY
Annual Giving
$8.0M
-13.5% YoY
Grant Count
24
+4.3% YoY
Avg Grant Size
$331K
-17.1% YoY
Mission & Focus Areas
IAVI's mission is to translate scientific discoveries into affordable, globally accessible public health solutions. The organization was founded specifically to address the dire need for an HIV/AIDS vaccine to end the AIDS pandemic.
Primary Program Areas:
Research and Development: IAVI conducts scientific and clinical research in Africa, India, Europe, and the United States to develop vaccines and antibodies. The organization advances scientific discovery through unique collaborations among academia, industry, local communities, governments, and funders. Vaccine and antibody candidates undergo rigorous clinical evaluation among key populations to establish safety and efficacy. This work strengthens healthcare infrastructure and scientific capacity in countries where clinical partners operate. To date, IAVI and its partners have advanced dozens of HIV vaccine candidates into early-stage clinical trials, including vaccines that have yielded promising results.
Current Portfolio: IAVI is pioneering vaccine and monoclonal antibody development for HIV, tuberculosis, and emerging infectious disease threats with pandemic potential.
Grantmaking
According to the most recent filing data, IAVI distributed approximately **$33.7 million in total giving**. Grant awards typically range from $6,391 to $5,178,000, with average and median grant amounts varying by funding cycle.
Ready to take the next step with International Aids Vaccine?
Geographic Focus
Where this funder awards grants
IAVI conducts research and operations across multiple regions:
- Africa (including South Africa, Kenya, Zambia)
- India
- Europe
- United States
The organization operates in 10 countries total and maintains a presence in South Africa, Kenya, India, the Netherlands, and the United Kingdom.
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
As of December 2023:
| Metric | Amount |
|---|---|
| Total Revenue | $129.7 million |
| Total Expenses | $132.9 million |
| Total Assets | $124.2 million |
| Total Liabilities | $60.3 million |
Workforce: IAVI employs 233 people as of the most recent reporting period, with operations spanning multiple countries.
Financial Rating: IAVI received a Three-Star rating from independent charity evaluators, with an overall score of 89%, indicating strong accountability and financial management.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $129,852,638 | $124,233,943 | $128,948,484 |
| Revenue | $131,181,475 | $129,678,400 | $146,782,280 |
| Expenses | $143,043,595 | $132,896,237 | $131,188,762 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $2,295,284 | $2,762,423 | $-178,814 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
105 grants across all recorded years
Giving History
Grant recipients and amounts by year
Among its reported 2024 grants, the largest include The Scripps Research Institute - Osp ($2,739,912), Fhi Clinical Inc ($1,375,993), Boston University ($936,607).
| Recipient | Purpose | Amount |
|---|---|---|
| THE SCRIPPS RESEARCH INSTITUTE - OSP LA JOLLA, CA | RESEARCH & DEVELOPMENT | $2,739,912 |
| TEXAS BIOMEDICAL RESEARCH INSTITUTE SAN ANTONIO, TX | RESEARCH & DEVELOPMENT | $61,388 |
| RESILIENCE GOVERNMENT SERVICES INC ALACHUA, FL | RESEARCH & DEVELOPMENT | $520,971 |
| LA JOLLA INSTITUTE FOR ALLERGY & IMMUNOLOGY LA JOLLA, CA | RESEARCH & DEVELOPMENT | $277,125 |
| EMORY UNIVERSITY ATLANTA, GA | RESEARCH & DEVELOPMENT | $352,302 |
| UNIVERSITY OF NORTH CAROLINE CHAPEL HILL CHAPEL HILL, NC | RESEARCH & DEVELOPMENT | $138,380 |
| THE MITCHELL GROUP INC (TMG) WASHINGTON, DC | RESEARCH & DEVELOPMENT | $168,266 |
| BOSTON UNIVERSITY BOSTON, MA | RESEARCH & DEVELOPMENT | $936,607 |
| LSB RESEARCH GROUP LLC MILES, TX | RESEARCH & DEVELOPMENT | $47,500 |
| SEATTLE CHILDREN'S HOSPITAL SEATTLE, WA | RESEARCH & DEVELOPMENT | $309,599 |
Leadership & Key People
Leadership team and compensation from IRS filings
Key executives include:
- Sandeep Mathur – Associate Director
- Min Ding – General Counsel
- Gaudensia Mutua – Medical Director
- Gretchen Meller – Senior Director, Project Management
- Esther Mungai-okech – Senior Director, Global Access
- Harriet Park – Executive Director, Global Clinical Operations
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| MARK B FEINBERG | PRESIDENT/CEO | 35 | $718,500 |
| ERIC PAUL GOOSBY | BOARD CHAIR | 2 | — |
| ROBERT GOLDBERG | BOARD TREASURER | 2 | — |
| LINDA-GAIL BECKER | BOARD MEMBER | 1 | — |
| DAVID BLUMBERG | BOARD MEMBER | 1 | — |
| JIM CONNOLLY | BOARD MEMBER | 1 | — |
| MARK DYBUL | BOARD MEMBER | 1 | — |
| WAFAA EL-SADR | BOARD MEMBER | 1 | — |
| ALEXIS M PINTO | BOARD MEMBER | 1 | — |
| JOHN W SHIVER | BOARD MEMBER | 1 | — |
| SUSAN SILBERMANN | BOARD MEMBER | 1 | — |
| ANNE MARTIN SIMONDS | BOARD MEMBER | 1 | — |
| RAJEEV VENKAYYA | BOARD MEMBER | 1 | — |
| MARIJKE WIJNROKS | BOARD MEMBER | 1 | — |
| ANA CESPEDES MONTOYA | CHIEF OPERATING OFFICER | 35 | $552,506 |
| MARIO GAGLIANO | CHIEF PEOPLE OFFICER, VP OF HR | 35 | $364,310 |
| MIN DING | GENERAL COUNSEL/BOARD SECRETARY | 35 | $368,570 |
| LOUIS D SCHWARTZ | ASST. SEC., CHIEF FIN. & ADMIN OFF. | 35 | $353,545 |
| BRANDON SAFT | DEPUTY CHIEF FINANCIAL OFFICER | 35 | $255,811 |
| SWATI GUPTA | VP, HEAD OF EID AND EPIDEMIOLOGY | 35 | $402,341 |
| CHRISTOPHER PARKS | ASS. VP, VIRAL VACC. & HEAD OF DDL | 35 | $380,753 |
| DAGNA LAUFER | VP AND HEAD OF CLINICAL DEVELOPMENT | 35 | $402,844 |
| MARION GRUBER | VP, PUBLIC HEALTH & REG. SCIENCE | 35 | $383,236 |
| SANGEETHA SAGAR | VICE PRESIDENT, PDC | 35 | $384,858 |
Recent News & Activity
Recent developments and announcements
IAVI has been actively involved in major HIV vaccine research initiatives:
ZAMBIA TO BENEFIT FROM A USAID $45 MILLION GRANT FOR HIV VACCINE RESEARCHUSAID awarded $45 million to African scientists developing HIV vaccines, with IAVI as a partner organization
USAID awards $45 Million to African scientists developing HIV vaccineNIH awarded $31 million for HIV/AIDS vaccine immunology and immunogen discovery
USAID awards $45 Million to African scientists developing HIV vaccineIAVI launched a Phase 1 clinical trial of an HIV vaccine in Africa to evaluate immune responses to highly networked HIV T-cell epitopes
USAID awards $45 Million to African scientists developing HIV vaccineZambia received a USAID $45 million grant for HIV vaccine research and development, with IAVI involvement
USAID awards $45 Million to African scientists developing HIV vaccineSubject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What does International Aids Vaccine fund?
IAVI's mission is to translate scientific discoveries into affordable, globally accessible public health solutions. The organization was founded specifically to address the dire need for an HIV/AIDS vaccine to end the AIDS pandemic. **Primary Program Areas:** **Research and Development:** IAVI conducts scientific and clinical research in Africa, India, Europe, and the United States to develop vaccines and antibodies. The organization advances scientific discovery through unique collaborations a…
How do I apply for a grant from International Aids Vaccine?
According to the most recent filing data, IAVI distributed approximately **$33.7 million in total giving**. Grant awards typically range from $6,391 to $5,178,000, with average and median grant amounts varying by funding cycle. The organization's grantmaking focuses on Education, Philanthropy, Voluntarism & Grantmaking, and Human Services, with primary geographic concentration in Massachusetts, California, and Washington.
Where does International Aids Vaccine make grants?
IAVI conducts research and operations across multiple regions: • **Africa** (including South Africa, Kenya, Zambia) • **India** • **Europe** • **United States** The organization operates in 10 countries total and maintains a presence in South Africa, Kenya, India, the Netherlands, and the United Kingdom.
What size grants does International Aids Vaccine award?
In 2024, International Aids Vaccine awarded 24 grants totaling $8.0M — an average of about $331K per grant, based on its IRS Form 990 filings.
What is International Aids Vaccine's EIN?
International Aids Vaccine's EIN (Employer Identification Number) is 13-3870223. IRS Form 990 filing data is available on this page for 2020–2024.
Explore Open Grants
Browse active grant opportunities in International Aids Vaccine's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Morgan Stanley Global Impact Funding Trust Inc
INDIANAPOLIS, IN
Assets
$9.1B
Grants
19,253
Total Given
$1.2B
National Philanthropic Trust
JENKINTOWN, PA
Assets
$42.2B
Grants
18,583
Total Given
$5.1B
Emory University
ATLANTA, GA
Assets
$22.2B
Grants
352
Total Given
$240.1M
Jpmorgan Chase Foundation
NEW YORK, NY
Assets
$1.2B
Grants
10,334
Total Given
$202.5M
Vanguard Charitable Endowment Program
SOUTHEASTERN, PA
Assets
$22.2B
Grants
24,269
Total Given
$3.0B
The Trustees of Columbia University
NEW YORK, NY
Assets
$24.8B
Grants
440
Total Given
$181.5M
Charities Aid Foundation America
ALEXANDRIA, VA
Assets
$444.9M
Grants
10,157
Total Given
$466.3M
The Simons Foundation Inc
NEW YORK, NY
Assets
$4.5B
Grants
1,727
Total Given
$272.0M
Trustees of Boston University
BOSTON, MA
Assets
$8.5B
Grants
263
Total Given
$92.0M
Georgetown University
WASHINGTON, DC
Assets
$6.0B
Grants
193
Total Given
$35.4M
Vanderbilt University Medical Center
NASHVILLE, TN
Assets
$6.6B
Grants
234
Total Given
$112.3M
Alzheimer's Disease & Related Disorders
CHICAGO, IL
Assets
$523.7M
Grants
79
Total Given
$73.3M
Data last updated June 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with International Aids Vaccine on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities